Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
STAT3 inhib
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
danvatirsen
(AZD9150) / AstraZeneca, Flamingo Therapeutics
dimethylamino micheliolide
(ACT001) / Tianjin Suntech Pharma
OPB-111077
/ Otsuka
niclosamide topical
(ATx 201) / UNION Therap
TTI-101 oral
/ Tvardi Therap
OPB-31121
/ Otsuka
Sulforadex
(sulforafan alfadex) / Evgen Pharma, STALICLA
atiprimod
(SK&F106615) / Synergy Pharma
niclosamide
(DWRX2003) / Daewoong Pharma
HL237
/ Hanlim Pharma
WP1066
/ Moleculin
golotimod
(SCV 07) / SciClone
niclosamide
(FW-1022) / First Wave Bio
niclosamide novel solution
/ Bayer
propranolol/etodolac
(VT-11CR) / Vicus
APX3330
/ Apexian, Ocuphire Pharma
SCR430
/ SupremeCure Pharma, RaND Biosciences
WP1220
/ WPD Pharma
curcumin/doxorubicin
(iMX-110) / Immix Biopharma
natura-alpha
(TAK-114) / Natrogen Therap, Takeda
NT219
/ Purple Biotech
pyrimethamine
(GLG-801) / GLG Pharma
